Gefjon Pharma ApS — Credit Rating and Financial Key Figures
CVR number: 44512971
Ole Maaløes Vej 3, 2200 København N
Thomas@gefjonpharma.com
tel: 50899528
www.gefjonpharma.com
Income statement (kDKK)
2024 | |
|---|---|
| Fiscal period length | 12 |
| Net sales | |
| Gross profit | 469.57 |
| Employee benefit expenses | - 717.51 |
| EBIT | - 247.94 |
| Other financial income | 0.10 |
| Other financial expenses | -0.00 |
| Pre-tax profit | - 247.84 |
| Income taxes | 52.33 |
| Net earnings | - 195.50 |
Assets (kDKK)
2024 | |
|---|---|
| Development expenditure | 945.04 |
| Intangible assets total | 945.04 |
| Tangible assets total | |
| Investments total | |
| Long term receivables total | |
| Inventories total | |
| Prepayments and accrued income | 6.26 |
| Current other receivables | 36.30 |
| Current deferred tax assets | 52.33 |
| Short term receivables total | 94.88 |
| Cash and bank deposits | 4 291.38 |
| Cash and cash equivalents | 4 291.38 |
| Balance sheet total (assets) | 5 331.31 |
Equity and liabilities (kDKK)
2024 | |
|---|---|
| Share capital | 40.00 |
| Profit of the financial year | - 195.50 |
| Shareholders equity total | - 155.50 |
| Non-current loans from credit institutions | 4 000.00 |
| Non-current liabilities total | 4 000.00 |
| Current bonds | 400.00 |
| Current trade creditors | 66.28 |
| Current owed to participating | 136.19 |
| Other non-interest bearing current liabilities | 226.85 |
| Accruals and deferred income | 657.50 |
| Current liabilities total | 1 486.82 |
| Balance sheet total (liabilities) | 5 331.31 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.